Research Updates

Home » Research Updates

FDA Grants Approval of New Pediatric Glioma Drug to Day One, a Biopharma Co-founded by CureSearch Board Member Dr. Samuel Blackman

Pediatric low-grade glioma (pLGG) is the most common form of pediatric brain cancer. Day One’s OJEMDA™ is the first targeted treatment for pLGG tumors with BRAF fusions and mutations. Last week, on April 23, 2024, Day One Biopharmaceuticals was granted Accelerated […]

FDA Grants Approval of New Pediatric Glioma Drug to Day One, a Biopharma Co-founded by CureSearch Board Member Dr. Samuel Blackman Read More »

High-risk neuroblastoma in children has a grim outlook. Dr. Jonus is fighting to change that.

Neuroblastoma is the most common extracranial solid tumor of childhood arising within the developing nervous system. Approximately half of neuroblastoma patients are diagnosed with high-risk disease, which is especially aggressive with a 50% survival rate. If a child’s high-risk neuroblastoma

High-risk neuroblastoma in children has a grim outlook. Dr. Jonus is fighting to change that. Read More »

Dr. Hunter Jonus

CureSearch for Children’s Cancer receives gift to support promising immunotherapy trial

Funds to support cutting-edge immunotherapy trial for pediatric high-grade glioma  Bethesda, MD – February 8, 2020  – CureSearch for Children’s Cancer has received a $1 million gift from the Norcross Family Foundation in support of a first-in-human, phase I/II clinical trial testing

CureSearch for Children’s Cancer receives gift to support promising immunotherapy trial Read More »

Elias Sayour, MD, PhD

From Bench to Bedside in 18 Months: How collaboration landed adolescent-young adult (AYA) patients in a clinical trial

“We were fortunate that CureSearch had just launched their Catapult Award program….It enabled researchers to access up to $2.5M in funding over three years, through a streamlined application process, rather than contending with multiple applications for smaller grants which would have lengthened

From Bench to Bedside in 18 Months: How collaboration landed adolescent-young adult (AYA) patients in a clinical trial Read More »

An Innovative Treatment Approach for DIPG: CureSearch for Children’s Cancer Partners with SebastianStrong Foundation to Fund Promising New Research

Contact: Tiffani CopelandSenior Vice President, Development & CommunicationsCureSearch for Children’s CancerEmail: tiffani.copeland@curesearch.org Bethesda, MD – July 30, 2020 – CureSearch for Children’s Cancer, in partnership with the SebastianStrong Foundation, has awarded a $225,000 Young Investigator grant to Yale Cancer Center’s

An Innovative Treatment Approach for DIPG: CureSearch for Children’s Cancer Partners with SebastianStrong Foundation to Fund Promising New Research Read More »

CureSearch Research Addresses Critical Unmet Need For Safe, Effective Pediatric Brain Cancer Treatments

CureSearch Research Funding DrivesNew Brain Cancer Treatments May is National Brain Tumor Awareness Month, highlighting a critical topic in the childhood cancer community as brain cancers account for 25% of all childhood and adolescent cancer diagnoses. Brain tumor types include medulloblastoma (the most common), high- and low-grade glioma, Primitive

CureSearch Research Addresses Critical Unmet Need For Safe, Effective Pediatric Brain Cancer Treatments Read More »

National Volunteer Week Spotlight: Industry Advisory Council champions pediatric drug development from within

As we work to find new and less-toxic treatments for pediatric cancers, we know that smarter research funding is just one part of the solution. Long-term solutions require a seismic shift in the existing pediatric drug development process. This change

National Volunteer Week Spotlight: Industry Advisory Council champions pediatric drug development from within Read More »

Volunteer Week 2020

Pin It on Pinterest

Scroll to Top